Olema Pharmaceuticals, Inc. (OLMA)
NASDAQ: OLMA · IEX Real-Time Price · USD
11.32
+0.12 (1.07%)
At close: Mar 28, 2024, 4:00 PM
10.95
-0.37 (-3.27%)
After-hours: Mar 28, 2024, 7:29 PM EDT

Olema Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Net Income
-96.66-104.79-71.1-23.99-4.32-2.2
Depreciation & Amortization
1.671.661.390.010.010.01
Share-Based Compensation
17.2618.8315.913.1100
Other Operating Activities
-62.243.11-0.861.230.01
Operating Cash Flow
-83.73-82.07-50.69-19.87-3.08-2.18
Capital Expenditures
0.01-0.36-1.58-0.0600
Change in Investments
-4.8791.84-273.86000
Investing Cash Flow
-4.8591.48-275.44-0.0600
Share Issuance / Repurchase
133.420.481.39221.1900
Debt Issued / Paid
0003.0900.32
Other Financing Activities
---134.12-4.93
Financing Cash Flow
133.420.481.39358.405.25
Net Cash Flow
44.849.89-324.74338.48-3.083.08
Free Cash Flow
-83.71-82.43-52.27-19.92-3.08-2.18
Free Cash Flow Per Share
-1.85-2.06-1.32-2.84-1.19-0.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).